Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics, Inc.verified

BOLT

Price:

$0.4395

Market Cap:

$16.85M

Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors; BDC-2034, a carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers; and BDC-3042, a Dectin-2 agonist antibody program developed to repolarize critical cells in the tumor microenvironment by targeting cell-surface receptors on macrophages. It is also develo...[Read more]

Industry

Biotechnology

IPO Date

2021-02-05

Stock Exchange

NASDAQ

Ticker

BOLT

The Enterprise Value as of March 2025 (TTM) for Bolt Biotherapeutics, Inc. (BOLT) is 34.85M

According to Bolt Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 34.85M. This represents a change of -24.68% compared to the average of 46.27M of the last 4 quarters.

Bolt Biotherapeutics, Inc. (BOLT) Historical Enterprise Value (quarterly & annually)

How has BOLT Enterprise Value performed in the past?

The mean historical Enterprise Value of Bolt Biotherapeutics, Inc. over the last ten years is 413.71M. The current 34.85M Enterprise Value has changed 742.48% with respect to the historical average. Over the past ten years (40 quarters), BOLT's Enterprise Value was at its highest in in the December 2020 quarter at 1.03B. The Enterprise Value was at its lowest in in the September 2001 quarter at 0.

Quarterly (TTM)
Annual

Average

413.71M

Median

180.23M

Minimum

38.44M

Maximum

1.17B

Bolt Biotherapeutics, Inc. (BOLT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Bolt Biotherapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 281.62%

Maximum Annual Enterprise Value = 1.17B

Minimum Annual Increase = -84.60%

Minimum Annual Enterprise Value = 38.44M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202438.44M-25.74%
202351.76M-16.43%
202261.93M-65.64%
2021180.23M-84.60%
20201.17B6.07%
20191.10B281.62%

Bolt Biotherapeutics, Inc. (BOLT) Average Enterprise Value

How has BOLT Enterprise Value performed in the past?

The current Enterprise Value of Bolt Biotherapeutics, Inc. (BOLT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

50.71M

5-year avg

300.61M

10-year avg

413.71M

Bolt Biotherapeutics, Inc. (BOLT) Enterprise Value vs. Peers

How is BOLT’s Enterprise Value compared to its peers?

Bolt Biotherapeutics, Inc.’s Enterprise Value is less than Assembly Biosciences, Inc. (46.53M), greater than Neoleukin Therapeutics, Inc. (-6333315.00), less than Instil Bio, Inc. (204.42M), greater than CytomX Therapeutics, Inc. (20.72M), greater than Achilles Therapeutics plc (-21604000.00), greater than Spero Therapeutics, Inc. (-24776896.00), less than Nuvation Bio Inc. (604.65M), greater than NextCure, Inc. (-6914844.00),

CompanyEnterprise ValueMarket cap
46.53M$81.79M
-6333315.00$8.20M
204.42M$126.34M
20.72M$49.39M
-21604000.00$60.83M
-24776896.00$46.89M
604.65M$631.46M
-6914844.00$14.86M

Build a custom stock screener for Bolt Biotherapeutics, Inc. (BOLT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bolt Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bolt Biotherapeutics, Inc. (BOLT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bolt Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Bolt Biotherapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Bolt Biotherapeutics, Inc. (BOLT)?

What is the 3-year average Enterprise Value for Bolt Biotherapeutics, Inc. (BOLT)?

What is the 5-year average Enterprise Value for Bolt Biotherapeutics, Inc. (BOLT)?

How does the current Enterprise Value for Bolt Biotherapeutics, Inc. (BOLT) compare to its historical average?